[1]Byrd TF, Davis LE. Multidrug-resistant tuberculous meningitis. Curr Neurol Neurosci Rep,2007, 7(6):470-475.[2]World Health Organization.Global tuberculosis control:epidemiology,strategy,financing.Geneva:WHO,2009.[3]王黎霞. 中国耐多药结核的控制亟待加强.中华结核和呼吸杂志,2009,32(8):561-563.[4]Caminero JA. Treatment of multidrug-resistant tuberculosis:evidence and controversies. Int J Tuberc Lung Dis,2006,10(8):829-837.[5]唐神结, 肖和平, 张青. 耐多药结核病化疗研究的新进展.中华结核和呼吸杂志,2009,32(8):617-620.[6]中国防痨协会. 耐药结核病化学治疗指南(2009).中国防痨杂志, 2010,32 (4):181-198.[7]肖和平. 耐药结核病防治手册. 北京: 人民卫生出版社,2009:87-88. [8]张敦熔. 现代结核病学.北京:人民军医出版社,2000:344-345.[9]何李佳. 脑脊液置换联合鞘内给药治疗结核性脑膜炎24例疗效分析. 检验医学与临床,2010,7(12):1216-1217.[10]Pardridge WM. Drug targeting to the brain. Pharma Res,2007,24(9):1733-1744.[11]World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis:emergency update 2008. Geneva: WHO,2008: 50-75.[12]Rodríguze JC,Ruiz M,Lopez M,et al. In vitro activity of moxifloxacin,levofloxacin,gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents,2002,20(6):464-467.[13]Alffenaar JWC,de Vries PM,van Soolingen D,et al.Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.Antimicrob Agents Chemother,2008,52(6):2293-2295.[14]郭振勇,赵伟杰,刘菲.炎症和高渗溶液对莫西沙星透过血-脑脊液屏障影响的研究及疗效评价. 中国医院用药评价与分析,2010,10(9):822-823.[15]马玙,朱莉贞,潘毓萱. 结核病.北京: 人民卫生出版社,2006:517-519. [16]陈新谦,金有豫,汤光.新编药物学.16版.北京: 人民卫生出版社,2007:116-117.[17]周文琳,田荆芳.结核性脑膜炎389例临床分析及早期诊断的探讨. 临床肺科杂志,2009,14(5):626-628.[18]万洪光.结核性脑膜炎早期诊断与治疗中存在问题的分析.临床肺科杂志,2007,2(3):290.[19]魏伟立.结核性脑膜炎的早期诊断策略.中国医师进修杂志(综合1版),2006,29(1):52-53.[20]李军民.结核性脑膜炎45例早期诊断分析.中国误诊学杂志,2008,8(17):4257-4258.[21]李毅,王仲,王厚力,等.结核性脑膜炎的早期诊断标准分析.中华内科杂志,2007,46(3):217-219. |